Support for genetic testing among psychiatrists varies by the circumstances in which the test would be used. Perhaps least controversial is genetic testing of symptomatic patients. Many psychiatrists attending a CME course on psychopharmacology (n=352) who were surveyed by Finn et al. (2005) said they would use genetic testing if it could help clarify a diagnosis in adult or child patients showing symptoms of schizophrenia (adults 75%, children 75%), bipolar disorder (74% and 72%), or panic disorder (66% and 63%) (differences between groups were not significant [n.s.]). In a survey of clinical psychiatrists in New York City (n=64) and psychiatric genetics researchers (n=162), if a genetic test for schizophrenia were available, 72% of psychiatrists and 70% of researchers responded that they would test all first episode patients and 73% and 69% would test all patients with chronic schizophrenia (differences between groups, n.s.), while 22% and 36% would test all psychiatric patients (chi-square, p< 0.05) (DeLisi & Bertisch, 2006). If one person had a positive test, significantly more practicing psychiatrists (48%) than researchers (32%) would test the rest of the family
